HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs). by Paget, Sonia et al.
Himmelfarb Health Sciences Library, The George Washington University
Health Sciences Research Commons
Surgery Faculty Publications Surgery
1-10-2017
HIC1 (hypermethylated in cancer 1)
SUMOylation is dispensable for DNA repair but is
essential for the apoptotic DNA damage response
(DDR) to irreparable DNA double-strand breaks
(DSBs).
Sonia Paget
Marion Dubuissez
Vanessa Dehennaut
Joe Nassour
Brennan T Harmon
See next page for additional authors
Follow this and additional works at: http://hsrc.himmelfarb.gwu.edu/smhs_surgery_facpubs
Part of the Neoplasms Commons, Oncology Commons, and the Surgery Commons
This Journal Article is brought to you for free and open access by the Surgery at Health Sciences Research Commons. It has been accepted for inclusion
in Surgery Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact
hsrc@gwu.edu.
APA Citation
Paget, S., Dubuissez, M., Dehennaut, V., Nassour, J., Harmon, B., Spruyt, N., Loison, I., Abbadie, C., Rood, B., & Leprince, D. (2017).
HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage
response (DDR) to irreparable DNA double-strand breaks (DSBs).. Oncotarget, 8 (2). http://dx.doi.org/10.18632/oncotarget.13807
Authors
Sonia Paget, Marion Dubuissez, Vanessa Dehennaut, Joe Nassour, Brennan T Harmon, Nathalie Spruyt,
Ingrid Loison, Corinne Abbadie, Brian R Rood, and Dominique Leprince
This journal article is available at Health Sciences Research Commons: http://hsrc.himmelfarb.gwu.edu/smhs_surgery_facpubs/493
Oncotarget2916www.impactjournals.com/oncotarget
www.impactjournals.com/oncotarget/                    Oncotarget, 2017, Vol. 8, (No. 2), pp: 2916-2935
HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable 
for DNA repair but is essential for the apoptotic DNA damage 
response (DDR) to irreparable DNA double-strand breaks (DSBs)
Sonia Paget1, Marion Dubuissez1,4, Vanessa Dehennaut1, Joe Nassour1,5, Brennan 
T. Harmon2, Nathalie Spruyt1, Ingrid Loison1, Corinne Abbadie1, Brian R. Rood3, 
Dominique Leprince1
1University Lille, CNRS, Institut Pasteur de Lille, UMR 8161-M3T-Mechanisms of Tumorigenesis and Targeted Therapies, Lille, 
France
2Genomics Core, Children's National Medical Center, Washington DC, USA
3Center for Cancer and Immunology Research, Children's National Medical Center, Washington DC, USA
4Present Address: Maisonneuve-Rosemont Hospital Research Center, Maisonneuve-Rosemont Hospital, Boulevard 
l'Assomption Montreal, Canada 
5Present Address: The Salk Institute for Biological Studies, Molecular and Cell Biology Department, La Jolla, California, USA
Correspondence to: Dominique Leprince, email: dominique.leprince@ibl.cnrs.fr
Keywords: DNA damage response, HIC1, ATM, MTA1, SUMOylation
Received: June 14, 2016    Accepted: November 23, 2016    Published: December 07, 2016
ABSTRACT
The tumor suppressor gene HIC1 (Hypermethylated In Cancer 1) encodes 
a transcriptional repressor mediating the p53-dependent apoptotic response to 
irreparable DNA double-strand breaks (DSBs) through direct transcriptional repression 
of SIRT1. HIC1 is also essential for DSB repair as silencing of endogenous HIC1 in BJ-
hTERT fibroblasts significantly delays DNA repair in functional Comet assays. HIC1 
SUMOylation favours its interaction with MTA1, a component of NuRD complexes. 
In contrast with irreparable DSBs induced by 16-hours of etoposide treatment, we 
show that repairable DSBs induced by 1 h etoposide treatment do not increase HIC1 
SUMOylation or its interaction with MTA1. Furthermore, HIC1 SUMOylation is dispensable 
for DNA repair since the non-SUMOylatable E316A mutant is as efficient as wt HIC1 
in Comet assays. Upon induction of irreparable DSBs, the ATM-mediated increase of 
HIC1 SUMOylation is independent of its effector kinase Chk2. Moreover, irreparable 
DSBs strongly increase both the interaction of HIC1 with MTA1 and MTA3 and their 
binding to the SIRT1 promoter. To characterize the molecular mechanisms sustained 
by this increased repression potential, we established global expression profiles of BJ-
hTERT fibroblasts transfected with HIC1-siRNA or control siRNA and treated or not with 
etoposide. We identified 475 genes potentially repressed by HIC1 with cell death and 
cell cycle as the main cellular functions identified by pathway analysis. Among them, 
CXCL12, EPHA4, TGFβR3 and TRIB2, also known as MTA1 target-genes, were validated 
by qRT-PCR analyses. Thus, our data demonstrate that HIC1 SUMOylation is important 
for the transcriptional response to non-repairable DSBs but dispensable for DNA repair.
INTRODUCTION
The genomic integrity of all living organisms 
is constantly challenged by deleterious attacks due to 
endogenous or exogenous genotoxic stress. DNA damage 
and in particular DNA double-strand breaks (DSBs) are 
highly deleterious since they can be lethal if unrepaired 
or predispose to oncogenic transformation if misrepaired. 
To cope with these lesions, cells have developed multiple 
interacting pathways called the DNA damage response 
(DDR) that lead either to damage repair or to programmed 
cell death depending on the extent of the damage [1]. A 
multi-branched, highly coordinated signaling cascade 
of Post-Translational Modifications (PTM) allows the 
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effective recruitment, stabilization and retention at DSBs 
of numerous proteins including sensors, mediators and 
effectors of the DDR [2]. A major transducer of DNA 
damage signaling in the case of DSBs is the activation 
of the PIKKs (Phosphatidylinositol 3 kinase-like protein 
kinase) ATM or DNA-PKcs proteins. In particular, the 
apical ATM kinase phosphorylates hundreds of proteins 
including histones (H2AX), repair factors (BRCA1), 
its effector kinase (CHK2) or transcription factors such 
as P53 [3]. Previous studies demonstrated that together 
with P53, SIRT1 and the tumor suppressor gene HIC1 
(Hypermethylated in cancer 1), which is epigenetically 
silenced by promoter hypermethylation in many types 
of human cancers [4, 5], plays a critical role in the DNA 
damage response [6–8]. Indeed, HIC1 is a direct target-
gene of P53 and upon induction of irreparable DSBs, 
HIC1 regulates the p53-dependant apoptotic DNA damage 
response [6]. When treated overnight with etoposide, 
a DSB inducer, wt Murine Embryo Fibroblasts (MEFs) 
rapidly begin to die whereas Hic1–/– MEFs are resistant 
to apoptosis. Conversely, re-expression of HIC1 in MCF-7 
cells through adenoviral infection restores their sensitivity 
to P53-induced apoptosis [6]. This effect relies mainly on 
the HIC1-mediated direct transcriptional repression of 
SIRT1, which deacetylates and inactivates P53 allowing 
cells to by-pass P53 induced apoptosis and survive DNA 
damage [6]. Recently, we have shown that HIC1 is also 
a key player in the response to repairable DNA damage. 
Down-regulation of endogenous HIC1 expression through 
RNA interference in normal human fibroblasts treated for 
1 hour with Etoposide delays DNA repair, as shown by 
functional comet assays [8].
HIC1 encodes a transcriptional repressor containing 
an N-terminal BTB domain and five C-terminal C2H2 
Krüppel-like Zinc fingers [9] We have shown that HIC1 
interacts with 4 major co-repressors complexes involved 
in chromatin remodelling and epigenetic regulation; 
CtBP, SWI/SNF, NuRD and the Polycomb PRC2 
complex [9]. In particular, we have demonstrated through 
yeast two-hybrid screening and various biochemical 
approaches that HIC1 interacts with the C-terminal 
region of MTA1, a core component of NuRD, through 
a SUMOylation consensus motif in the HIC1 central 
region [10, 11]. SUMOylation is a highly dynamic and 
labile PTM that plays a key role in the assembly of multi-
protein complexes [12]. The HIC1-MTA1 interaction is 
regulated by two mutually exclusive PTM of Lysine 314, 
promotion by SUMOylation and inhibition by acetylation 
[10, 11]. Previously, we demonstrated that irreparable 
DSBs induced by a 16 h treatment with etoposide 
result in a specific increase of HIC1 SUMOylation in 
an ATM-dependant manner [8]. This increase of HIC1 
SUMOylation is correlated with an increased interaction 
of endogenous HIC1 and MTA1 proteins in etoposide 
treated normal human fibroblasts, thereby favouring the 
recruitment of NuRD repressive complexes onto HIC1 
target genes [8]. This provides the first mechanism by 
which the transcriptional repression function of HIC1 is 
activated upon DNA damage. 
In this study, we further investigated the function and 
regulation of HIC1 SUMOylation during the DNA damage 
response to repairable and non-repairable DSBs. First, we 
demonstrate that HIC1 SUMOylation does not increase 
upon induction of repairable DSBs by a 1 h etoposide 
treatment. In addition, results from functional DNA 
repair assays such as Comet assays using overexpression 
of wt or non-SUMOylatable (E316A) HIC1 in Cos-7 
cells that do no express endogenous HIC1 demonstrated 
that SUMOylation on Lysine 314 is not implicated in 
DSB repair. Indeed, the efficiency and kinetics of repair 
exhibited by the E316A point mutant and wild-type HIC1 
are virtually indistinguishable. Furthermore, we show 
that the increased SUMOylation of HIC1 in the presence 
of irreparable DSBs induced by a 16 hours etoposide 
treatment is primarily dependent on ATM which is 
stabilized and activated on chromatin but independent 
of its nucleoplasmic effector kinase CHK2. As for the 
HIC1-MTA1 interaction, we showed that it depends on 
a non-covalent interaction between SUMOylated HIC1 
and the SUMO-interacting motif (SIM) in the C-terminal 
part of MTA1. Furthermore, we demonstrated that HIC1 
also interacts with the related corepressor MTA3 and that 
irreparable DSBs increase this interaction, as shown for 
MTA1. By ChIP experiments, we showed that induction 
of irreparable DSBs results in an increased recruitment 
of MTA1, MTA3 and also of HIC1 onto HIC1-response 
elements (HiRE) in the SIRT1 promoter. To further 
characterize the molecular mechanisms sustained by 
this increased repression potential, we established global 
expression profiles of BJ-hTERT fibroblasts transfected 
with HIC1-siRNA or control siRNA and treated or not 
with etoposide. We identified 475 genes potentially 
repressed by HIC1 with cell death and cell cycle as the 
main cellular functions identified by pathway analysis. 
Cross referencing this list with the 1024 MTA1 target 
genes identified by comparing wt MEFs (Murine 
Embryos Fibroblasts) with Mta1 –/– MEFs identified 17 
common genes. Among them, CXCL12, EPHA4, LPHN2, 
TGFβR3 and TRIB2 were shown to be activated in siHIC1 
fibroblasts and to be more repressed in control cells treated 
with Etoposide to increase HIC1 SUMOylation.  
In summary, our results demonstrate that HIC1 
SUMOylation is dispensable for DNA repair but is 
important for the p53-dependent apoptotic transcriptional 
response to irreparable DSBs, notably through the 
recruitment of MTA1 or MTA3 containing NuRD 
repressive complexes to the SIRT1 promoter and other 
potential direct target genes. 
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RESULTS 
Repairable DNA DSBs do not result in a PIKK-
dependant increase of HIC1 SUMOylation and 
interaction with MTA1
We previously demonstrated that induction of 
non-repairable DSBs by overnight (16 h) treatment of 
transfected HEK293T cells with 20 μM etoposide, an 
inhibitor of topoisomerase II known to induce DSBs, 
results in a significant increase of HIC1 SUMOylation [8]. 
Such a prolonged assault leads to the accumulation of non-
repairable damage resulting in a p53-dependent apoptotic 
response [6]. HEK293T cells were transfected with the 
empty FLAG or FLAG-HIC1 expression vectors with or 
without an expression vector for His-SUMO2 and/or the 
de-SUMOylase SENP2. 48 hours after transfection, cells 
were treated with 20 μM etoposide for 16 hours to induce 
non-repairable DNA damage and immediately lysed 
under denaturing conditions. Total extracts were then 
analyzed by Western blot with anti-FLAG monoclonal 
antibodies to detect HIC1 and its SUMOylated forms. 
As shown in Figure 1A, the isoform of higher molecular 
weight, corresponding to the SUMOylated form of HIC1, 
disappeared in presence of SENP2 and is significantly 
increased after 16 h etoposide treatment, as previously 
shown [8]. 
Since endogenous HIC1 also activates the kinetics 
and/or efficiency of DSB repair in BJ-hTERT fibroblasts, 
we next wanted to address the importance of HIC1 
SUMOylation in the repair process [8]. In striking contrast 
with the ATM-dependent increase of HIC1 SUMOylation 
observed in HEK293T cells treated for 16 hours with 
etoposide [8], HIC1 SUMOylation levels do not increase 
after the induction of repairable DSBs by a short (1 hour) 
etoposide treatment (Figure 1B, compare lanes 3 and 
4 to lanes 7 and 8). This HIC1 SUMOylation is also 
independent of ATM activation since its level remains 
constant when cells are pre-incubated for 1 h with the 
specific ATM inhibitor Ku-55939 prior to the 1 hour 
etoposide treatment (Supplementary Figure S1A). 
DNA-damaging agents that create DSBs activate 
a DDR primarily relying on the activation of kinases of 
the PIKKs (Phosphatidylinositol 3 kinase-like protein 
kinase) family, ATM or DNA-PKcs proteins [13]. After 
induction of repairable damage, inhibition of ATM 
and DNA-PKcs by Wortmaninn, a PI3K inhibitor also 
inhibiting PIKKs, or by pharmacological inhibitors 
specific for each PIKK, has no significant effects on HIC1 
SUMOylation (Figure 1C). Previously, we demonstrated 
that SUMOylation potentiates the repressive potential 
of HIC1 by favoring its interaction with MTA1 [10, 11], 
most notably during the response to non-repairable DSBs 
[8]. However, after induction of repairable DSBs, co-
immunoprecipitation experiments in HEK293T cells 
transfected with expression vectors for HIC1 and MTA1 
clearly failed to demonstrate a stronger interaction 
between these two proteins (Figure 1D).
In conclusion, repairable and non-repairable 
DSBs, induced by 1 hour or 16 hours etoposide 
treatments respectively, have different impacts on HIC1 
SUMOylation and hence on the interaction between 
HIC1 and the NuRD complex, potentially in line with 
the biological outcomes of the DNA damage responses to 
these different genotoxic insults, repair or apoptosis.
Lack of HIC1 SUMOylation does not impair 
DNA repair
To address the functional impact of HIC1 
SUMOylation on the time-course of DSBs repair, we first 
tested wt HIC1 and the empty FLAG expression vector 
in the neutral Comet assay which specifically measured 
DSBs at the level of individual cells. To that end, 48 
hours after transfection, Cos7 cells which do not express 
HIC1 at significant endogenous levels were treated for 1 
hour with etoposide before recovery in complete culture 
medium without etoposide for various times. As shown in 
Figure 2A, ectopic expression of HIC1 slightly accelerates 
DSBs repair notably during the early steps of recovery (2 h 
and 4 h). These observations are in close agreement with 
the slower repair induced in BJ-hTERT human fibroblasts 
by inactivation of endogenous HIC1 expression through 
siRNA interference [8]. We next compared the DNA repair 
capacity of HEK293T cells transfected with wt HIC1 or 
with the non SUMOylatable E316A point mutant. HIC1 
Lysine 314 can be acetylated and SUMOylated [10, 11]. 
Therefore, we used the E316A mutant (non SUMOylatable 
since the SUMOylation consensus is ϕKxE) instead of 
the K314R mutant since this latter would impede not 
only SUMOylation but also acetylation or any other 
potential post-translational modifications on this lysine 
residue [14]. Results showed that the same amount of 
DSBs were induced in HEK293T transfected with the two 
expression vectors. Furthermore, no salient differences 
were observed during the time-course recovery in normal 
medium of cells expressing the wt or the E316A SUMO-
deficient HIC1 mutant (Figure 2B–2D). Thus, these results 
unambiguously demonstrate that HIC1 SUMOylation on 
lysine K314 is not essential for DSBs repair.
HIC1 SUMOylation increase after 16 h etoposide 
treatment is dependent of ATM 
DSBs elicit a DNA damage response primarily 
relying on the activation of the ATM or DNA-PKcs 
kinases which have complementary and non-redundant 
functions [13, 15]. Whereas ATM has hundreds of 
substrates, DNA-PKcs phosphorylates a smaller group of 
proteins involved in DSBs end joining. [16]. We tried to 
inhibit ATM and DNA-PKcs by a 1 hour pre-treatment 
with Wortmaninn or with specific pharmacological 
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Figure 1: Repairable DNA double-strand breaks (DSBs) induced by a 1 hour etoposide treatment do not lead to 
an ATM-dependent increase of HIC1 SUMOylation. (A) Etoposide-induced non-repairable DSBs lead to an increase of HIC1 
SUMOylation. HEK293T cells were transfected with the indicated combination of empty FLAG, FLAG-HIC1, SENP2 and SUMO2 
expression vectors. 32 hours after transfection cells were incubated for 16 hours with 20 μM etoposide (+) or DMSO (–) as control before 
direct lysis in denaturing conditions. Total cell extracts were analyzed by Western Blotting (WB) using the indicated antibodies. (B) HEK 
293T cells were transfected with FLAG-HIC1 and treated with etoposide or DMSO for 1 hour or 16 hours. Cell extracts were prepared 
as described in panel A) and analyzed by immunoblotting using the indicated antibodies. Quantification of SUMO-HIC1 to total HIC1 
(FLAG) was performed with the Fujifilm MultiGauge software (Bottom Panel) (C) HEK 293T cells were transfected with FLAG-HIC1 
and treated with etoposide or DMSO for 1 hour. Transfected cells were pre-treated or not with the following inhibitors (Wortmannin; 
ATMi, ATM inhibitor and DNAPKcsi, DNA-PKcs inhibitor) 1 hour before etoposide treatment, as indicated. Cell extracts were prepared 
as described in panel B) and analyzed by immunoblotting using the indicated antibodies. (D) HEK293T cells were co-transfected with the 
indicated combinations of expression vectors for FLAG-HIC1 and MTA1 and then incubated for 1 hour in etoposide or with DMSO as 
control. After lysis in IPH buffer, cells extracts were co-immunoprecipitated with anti-HIC1 antibodies. The immunoprecipitates as well as 
2% of the whole cell extract (Input) were analyzed by Western blotting with the anti FLAG and anti MTA1 antibody. Note that the MTA1 
antibodies detect a doublet of endogenous proteins in non transfected cells whereas the ectopically expressed MTA1 protein co-migrates 
with the upper band of the doublet (arrowheads).
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inhibitors for each PIKK prior to a 16 hours etoposide 
treatment to induce non-repairable DSBs in the presence 
of these inhibitors as previously performed with the ATM 
specific inhibitor [8]. However, in these conditions where 
the DNA-PKcs inhibitor was kept on the cells for 17 
(1+16) hours, a strong cytotoxic effect precluding further 
analyses was observed (data not shown). To circumvent 
this technical problem, we then used siRNA interference 
to inactivate DNA-PKcs or ATM, as a positive control. 
Upon induction of irreparable damage, the increase of 
HIC1 SUMOylation was observed in cells tranfected with 
control siRNAs and also in cells transfected with a pool of 
siRNAs efficiently targeting ATM albeit to a lesser extent 
(Figure 3A, lanes 1 to 4 and Figure 3B). These findings 
therefore nicely confirmed our previous results obtained 
with the pharmacological ATM inhibitor, Ku-55933 [8]. 
Silencing of DNA-PKcs by siRNAs did not fully abolish 
the increase of HIC1 SUMOylation but did significantly 
Figure 2: HIC1 SUMOylation is not required for efficient DSBs repair. (A) Cos7 cells were transfected for 48 hours with wt 
FLAG-HIC1 or with the empty pcDNA3FLAG expression vector. Cells were either mock-treated with DMSO (–) or treated with 20 μM 
etoposide (+) for 1 hour. After removal of the drug, cells were allowed to recover in normal medium for various times (2, 4, 6 and 24 hours) 
and DSBs were monitored by neutral Comet assay. The percentage of Comet positive cells reflecting unrepaired DNA breaks is depicted 
after counting at least 100 cells in each condition. (B) Cos7 cells were transfected for 48 hours with wt FLAG-HIC1 or with the non-
SUMOylatable E316A point mutant. Neutral Comet assays were performed and analyzed as described in panel A). The error bar indicates 
mean +/– standard deviation of three independent experiments (NS: not significant). (C) Representative Comet images of mock-treated 
(DMSO) and of cells treated with etoposide for 1 hour after transfection of wt HIC1 or of E316A HIC1 with or without recovery in normal 
medium for 4 and 24 hours, respectively. (D) Western blot analyses of cells transfected with wt HIC1 or with E316A HIC1 Samples of 
cells in each condition were taken before the Comet assays and immediately lysed in Laemmli loading buffer. These whole cell extracts 
were analyzed by Western blot with anti-FLAG antibodies to detect HIC1 and its SUMOylated forms. γH2AX and actin levels were used 
as controls for DSB induction and equal loading, respectively.
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Figure 3: The SUMOylation increase of HIC1 upon induction of irreparable DSBs is dependent on ATM but 
independent of DNA-PKcs. (A) HEK293T cells were transfected either with nontargeted control siRNA (siCtrl), either with a pool 
of four siRNAs targeting ATM (siATM) or with a pool of four siRNAs targeting DNAPKcs (siDNAPKcs). The next day, these cells were 
transfected with a FLAG-HIC1 expression vector for 24 hours and were then treated with 20 μM etoposide (+) or mock-treated with DMSO 
(–) as control for 16 hours before direct lysis in denaturing conditions. Total cell extracts were analyzed by Western Blotting (WB) using 
the indicated antibodies. (B) Quantification of SUMO-HIC1. The HIC1 SUMOylated band in control conditions (siCtrl, DMSO 16 h; lane 1 
in panel A) was quantified with the Fujifilm MultiGauge software and given the arbitrary value of 1. The other HIC1 SUMOylated bands 
(lanes 2 to 6 in panel A) were quantified relative to this value. (C) HEK293T cells were transfected either with nontargeted control siRNA 
(siCtrl), a pool of four siRNAs targeting ATM (siATM) or with each individual siRNA from the pool targeting DNA-PKcs (siDNA-PKcs). 
Then, cells were treated with etoposide and total cell extracts were analyzed by Western blot on three different gels (two 6% polyacrylamide 
gels for DNAPK-cs and ATM; a 15% polyacrylamide gel for γH2AX, H2AX and actin) as described in panel A.
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impair it to levels similar to those obtained with ATM 
siRNAs (Figure 3A, lanes 5 and 6 and Figure 3B). 
However, in the control Western blots, we noticed that this 
pool of siRNAs targeting DNA-PKcs down regulate not 
only the expression of DNA-PKcs but also surprisingly 
the expression of ATM (Figure 3A, lanes 5 and 6). 
These results were confirmed by qRT-PCR analyses of 
ATM expression levels in the same transfected cells 
(Supplementary Figure S2). To explain this, we performed 
another experiment testing individually the four siRNAs 
of the pool targeting DNAPKcs. In Western blots, the three 
siRNAs that efficiently inhibit DNA-PKcs expression 
(#7, #8 and #9) also inhibit ATM expression whereas the 
siRNA DNA-PKcs #6 has no effect on DNAPK-cs and 
ATM expression (Figure 3C, lanes 5 to 12). As expected, 
the control siRNAs have no effect on ATM and DNAPK-
cs and the pool of siRNAs targeting ATM has no effect 
on DNA-PKcs expression (Figure 3A, lanes 1 to 4). After 
a 16 h etoposide treatment, the SUMOylation increase 
observed in cells transfected with the ATM siRNAs pool 
which express DNA-PKcs and in cells tranfected with 
the DNAPK-cs siRNAs pool, in which the expression 
of both DNAPK-cs and ATM are severely inhibited, 
appears reduced but similar (Figure 3A and 3B). Thus, the 
increase of HIC1 SUMOylation observed upon induction 
of irreparable DSBs appears to be primarily dependent 
upon ATM.
HIC1 SUMOylation increase is dependent on 
the apical kinase ATM but independent of its 
effector kinase Chk2
After detection of DSBs by sensors such as the 
MRN complex, DNA damage signaling is rapidly induced 
by the activation of the ATM/Chk2 pathway. Whereas 
the apical ATM kinase is recruited to and stabilized 
on the DSBs sites, its effector kinase Chk2 becomes 
phosphorylated by ATM at damage sites but then rapidly 
dissociates and is distributed throughout the nucleus to 
phosphorylate numerous downstream targets [2, 17]. To 
determine whether the HIC1 SUMOylation increase after 
irreparable DSB induction requires the complete activation 
of the ATM/Chk2 pathway and is dependent on both ATM 
and Chk2 activation, FLAG-HIC1-transfected cells were 
pre-incubated with C3742, a specific inhibitor of Chk2, 
prior to a 16 hour etoposide treatment (Figure 4A). Both 
the basal and enhanced SUMOylation of HIC1 observed 
after induction of irreparable DSBs remained unchanged 
in presence of the Chk2 inhibitor (Figure 4A, lanes 4 to 8). 
Similar results were obtained with cells treated with 
etoposide for 1 hour (Supplementary Figure S4). As 
controls for the effectiveness of the Chk2 inhibitor, we 
observed a strong decrease of Chk2 autophosphorylation 
on Serine 516 as well as of phosphorylation of P53 on 
Serine 20, a well-known target of Chk2 but no significant 
effects on two ATM substrates (T68Chk2 and γH2AX) or 
on ATM autophosphorylation (Figure 4A and 4B).
To confirm these results with an independent 
assay, we used siRNA interference to inactivate Chk2. 
We first demonstrated the efficiency of a pool of 
siRNAs (Dharmacon) targeting Chk2 by transfection in 
HEK293T grown in standard conditions (no etoposide 
treatment) followed by qRT-PCR and Western blot 
analyses (Figure 4C and 4D). Using this pool of siRNAs 
targeting Chk2, we further showed that the increase of 
HIC1 SUMOylation observed after a 16 hour etoposide 
treatment is not significantly affected by Chk2 inhibition 
(Figure 4D and 4E).
In conclusion, the increase of HIC1 SUMOylation 
upon induction of non-repairable DSBs is dependent upon 
the apical kinase ATM [8] but not its downstream effector 
kinase Chk2. Thus, these results strongly suggest that the 
increase of HIC1 SUMOylation occurs and plays a role in 
close proximity to chromatin where ATM is activated and 
stabilized consistent with the “on-site modification” model 
proposed for SUMOylation.
The SIM (SUMO-interacting motif) of MTA1 is 
required for the interaction with HIC1
Since the induction of non-repairable DSBs and 
the resulting increase in SUMOylation of HIC1 favors 
its interaction with MTA1, we further investigated the 
molecular mechanisms underpinning the HIC1-MTA1 
interaction with a focus on SUMOylation [8, 11]. A 
SUMOylated protein can interact non-covalently with 
another protein containing a SIM (SUMO-interacting 
motif) [14]. MTA1 contains in its C-terminal end a 
functional SIM motif DEPIVIED (Figure 5A) perfectly 
fitting with the most canonical class of SIM motifs, a 
hydrophobic core (V/I)X(V/I)(V/I) flanked by acidic 
amino acids [18, 19]. Interestingly, triple mutations in 
the hydrophobic core of the SIM motif in MTA1 (I711A/
V712A/I713A, referred to hereafter as AAA) abolished 
the interaction of MTA1 with HIC1 (Figure 5B, lane 5). 
MTA1 is also SUMOylated on Lysine 509, which is 
located in its C-terminal region [19]. However, in contrast 
with the AAA SIM mutant, wt MTA1 and the K509R non-
SUMOylatable mutant similarly interacted with HIC1 in 
co-immunoprecipitation experiments, demonstrating that 
MTA1 SUMOylation is not required for this interaction 
(Figure 5C, lane 5 and 6).
Thus, the SIM motif of MTA1 is essential for the 
interaction with HIC1, in agreement with the fact that 
HIC1 SUMOylation favors it, and thus highlights a 
SUMO-SIM non-covalent interaction between these two 
proteins [11]. However, the region of interaction between 
HIC1 and MTA1 previously defined by the prey isolated 
in the yeast two-hybrid screening as MTA1 amino-acids 
397-473 excluded this MTA1 SIM motif (Figure 5A) 
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Figure 4: The increase of HIC1 SUMOylation upon irreparable DSB induction by etoposide requires ATM but not its 
effector kinase Chk2. (A) HEK293T cells were transfected with the FLAG and FLAG-HIC1 vectors. 48 hours after transfection, cells 
were pre-incubated or not with the Chk2 inhibitor (Chk2i) for 1 hour and then with etoposide for 16 hours as indicated. Cell extracts were 
prepared and Western blotting was performed with the indicated antibodies. *refers to non-specific bands detected by the anti pS516Chk2 
(autophosphoylation) and by the anti pS20P53 (Chk2 target) antibodies. γH2AX and actin levels were used as controls for DSBs induction 
and equal loading, respectively. (B) To control for the inhibition of Chk2, HEK293T cells were transfected and pre-incubated or not with the 
Chk2 inhibitor (Chk2i) for 1 hour and then with etoposide for 16 hours exactly as in panel A) before lysis and Western blot analyses with 
the indicated antibodies (C) HEK293T cells grown in normal medium were transfected with siRNA control (siCtrl) or with a Chk2 siRNA 
pool (siChk2). Total RNAs were extracted and the mRNA expression levels of Chk2 were assessed by qRT-PCR. Values were normalized 
to 18S. (D) HEK293T cells were transfected either with non-target control siRNA (siCtrl) or with a Chk2 siRNA pool (siChk2) before 
being transfected with the indicated combination of FLAG, FLAG-HIC1 and SUMO-2 expression vectors. Cells were either incubated with 
DMSO (–) or with 20 μM etoposide (+) for 16 hours. Total cell extracts were prepared and analyzed by Western blotting with the indicated 
antibodies. *refers to a non-specific band detected by the anti pS516Chk2, used as a control for Chk2 kinase activity. γH2AX and actin 
levels were used as controls for DSBs induction and equal loading, respectively. (E) Quantification of SUMO-HIC1 to total HIC1 (FLAG) 
for lanes 5 to 8 in panel D) was performed with the Fujifilm MultiGauge software.
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and the HIC1 K314R non-SUMOylatable mutant still 
interacts with MTA1, albeit weakly [11]. To elucidate 
this interaction, we constructed another mutant of the 
full length HIC1 protein, hereafter referred to as HIC1 
ΔMKHEP, by deleting amino acids 305-326 encompassing 
this SUMOylation motif. In co-immunoprecipitation 
experiments, the ΔMKHEP HIC1 mutant interacts very 
weakly with ectopically expressed MTA1 proteins 
as compared to wt HIC1 (Figure 5D, lanes 5 and 6). 
Furthermore, this deletion mutant upon overexpression in 
HEK293T cells is almost unable to co-immunoprecipitate 
with endogenous MTA1 proteins (Figure 5E, lane 2). 
Reciprocally, we fused the isolated SUMOylation motif 
of HIC1 (amino acids 305-326) in frame with a C-terminal 
DNA-binding domain, a nuclear localization signal and 
an HA epitope in the Gal4-NLS-HA vector to mimic 
its localization in the full-length protein. However, this 
305-326-HIC1-Gal4 chimera despite being nuclear 
and displaying a strong repression potential in transient 
Luciferase reporter assays, is unable to significantly 
interact with MTA1 (data not shown).
All together these results suggest a complex, multi-
domain interaction between HIC1 and MTA1 with major, 
but not exclusive, roles played by the HIC1 SUMOylation 
motif and the MTA1 SUMO-interacting motif.
HIC1 interacts with MTA3 and this interaction 
increases upon induction of non-repairable DSBs
MTA1, the closely related MTA2 and the 
functionally distinct MTA3 proteins are found in a 
mutually exclusive manner in different specialized NuRD 
complexes [20, 21]. Given that HIC1 interacts with MTA1 
and this interaction is favoured by HIC1 SUMOylation [8, 
11], we thus investigated if HIC1 also interacts with MTA3 
and if this interaction increased upon induction of non-
repairable DSBs. Co-immunoprecipitation experiments 
(Co-IPs) in transiently transfected HEK293T cells 
demonstrated that HIC1 interacts with MTA3 and that this 
interaction strongly increased when cells were pre-treated 
with etoposide for 16 hours (Figure 6A, lanes 7 and 8). 
To correlate these results with promoter occupancy 
and transcriptional regulation, we next performed ChIP 
experiments with chromatin prepared from BJ-hTERT 
fibroblasts treated or not with etopside for 16 hours. 
Using high quality ChIP-grade antibodies for MTA3 
[22], these experiments demonstrated a strong enrichment 
of MTA3 binding onto the HIC1 responsive elements 
(HiRE) in the SIRT1 promoter [6, 11] upon induction of 
irreparable damage (Figure 6B). Thus, the increase of 
HIC1 SUMOylation after a 16 hours etoposide treatment 
is nicely correlated with an increase in HIC1-MTA3 
interaction, thus favoring the recruitment of MTA3 onto 
HIC1 direct target genes. Taken together, these results 
demonstrate that HIC1 can interact with the MTA1/MTA2 
and MTA3 proteins and hence with a wide variety of 
NuRD complexes and that these repressive complexes are 
favoured to repress some HIC1 target genes and notably 
SIRT1 during the apoptotic DNA damage response to non-
repairable DSBs.
Differential HIC1 recruitment on the SIRT1 
promoter upon induction of repairable versus 
non-repairable DSBs 
We next compared HIC1 binding of the SIRT1 
promoter upon induction of repairable or non-repairable 
DSBs. We first performed pilot ChIP experiments with 
BJ-hTERT cells treated or not with DMSO (vehicle) or 
Etoposide for various times. Whereas HIC1 is bound on 
the SIRT1 promoter in control (untreated) conditions, this 
binding is slightly decreased in the presence of DMSO, 
especially after the longest treatment times (6 hours) 
(Figure 7A). ChIP experiments conducted with BJ-
hTERT cells treated for 1 h with Etoposide detected a 
clear decrease of HIC1 binding to the SIRT1 promoter 
(Figure 7A). By contrast, a strong increase of HIC1 
binding is observed upon induction of non-repairable 
damage. Notably, SUMOylation of the related BTB/POZ 
transcriptional repressor PLZF also increases its DNA 
binding properties [23, 24]. In an independent experiment, 
HIC1 binding and the recruitment of MTA1 to the SIRT1 
promoter were also increased after a 16 hours etoposide 
treatment (Figure 7B, left columns). The proneuronal 
HIC1 target gene, ATOH1 and GAPDH were used as 
controls. Thus, these data demonstrate that the induction 
of non-repairable DSBs increased the binding of HIC1 and 
its SUMOylation-dependent partners, MTA1 and MTA3, 
to the SIRT1 promoter. 
A short 6 hours etoposide treatment is sufficient 
to induce a P53-dependent apoptotic response
HIC1 directly represses SIRT1 transcription to 
modulate the P53-dependent apoptotic response to non-
repairable double-strands breaks [6]. Our previous work [8] 
[11] and the results reported in this study all emphasize an 
increased HIC1 SUMOylation which favors its interaction 
with MTA1 or MTA3 in NuRD repressive complexes and 
hence enhances its transcriptional repression activity 
during the cellular response to irreparable DSBs (Figures 1 
and 5–7). However, a long, 16 hours etoposide treatment 
could induce a direct transcriptional effect mediated by 
HIC1 but also an indirect, “second-wave” effect mediated 
by P53 which is acetylated and hence activated through 
SIRT1 inhibition by HIC1. Indeed, in these conditions 
the pro-apototic Bax, Noxa and PUMA genes and the 
anti-apoptotic BCL-2 gene which are not known as direct 
target genes of HIC1 but as direct P53 target genes are 
activated or repressed, respectively by P53 [6]. To address 
this issue, we first performed a pilot time-course response 
of BJ-hTert fibroblasts to etoposide. BJ-hTERT cells 
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Figure 5: At least two domains in the C-terminal end of MTA1 are implicated in the interaction with HIC1. 
(A) Schematic drawing of the human MTA1 protein. The domains identified in MTA1 include the BAH (Bromo-associated homology), the 
ELM (Egl-27 and MTA1 homology), the SANT (SW13, ADA2, N-CoR and TF1118) and the GATA-like zinc finger. The region isolated 
in the two-hybrid screen with HIC1 is shown with the two first cysteines of the GATA zinc finger not present in the isolated prey, shown 
as lower-case letters underlined [11]. The Lysine 509, which is SUMOylated, and the C-terminal SIM motif are also shown with the 
hydrophobic core, IVI, underlined and the flanking acidic residues in bold [19]. (B) The SIM (SUMO-interacting motif) in the C-terminal 
end of MTA1 is required for its interaction with HIC1. After transfection with the indicated expression vectors, HEK293T cells lysates were 
immunoprecipitated with anti-c-myc antibodies. Immunoprecipitated samples [IP c-myc (MTA1)] and 1% of whole cell extracts (Input) 
were analyzed by immunoblotting with anti-HIC1 antibodies to detect co-immunoprecipitation. To control for IP efficiency, the membrane 
was stripped and probed with anti-MTA1 antibodies (the arrow head indicates a remnant of the HIC1 band). (C) SUMOylation of MTA1 
on Lysine K509 is not required for the HIC1-MTA1 interaction. A similar experiment was performed in HEK293T with expression vectors 
for wt MTA1 or its non-SUMOylatable version (K509R) and HIC1. In the top panel, *refers to a non-specific band detected. In the bottom 
panel, the arrowhead indicates a remnant of the MTA1 band. (D) The HIC1-MTA1 interaction is also strongly reduced by deletion of the 
HIC1 SUMOylation motif, ΔMKHEP. A similar Co-IP experiment was realized in HEK293T but with expression vectors for the wt FLAG-
HIC1 or the FLAG-HIC1 ΔMKHEP deletion mutant and wt MTA1. (E) Interaction of wt and ΔMKHEP HIC1 with endogenous MTA1 
proteins in HEK293T cells. Total extracts of HEK293T transfected with the indicated plasmids were analysed by Co-IP with anti-MTA1 
antibodies and immunoblotted with MTA1 and FLAG antibodies. Note that the endogenous MTA1 proteins in the immunoprecipitated 
materials or in the Inputs migrate as a doublet. 
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transfected with Control siRNAs or HIC1 siRNAs were 
treated with etoposide for 1, 6 and 16 hours and analyzed 
by Western blot for expression of the cell cycle inhibitor 
P21CIP1 which is a key factor mediating the P53 response 
and also a direct target gene of HIC1 [25]. A similar 
induction of P21CIP1 expression is observed after either 
6- or 16- hour etoposide treatments as well as a further 
increase in siHIC1-treated cells as expected for a HIC1 
direct target gene (Supplementary Figure S5A). Thus, a 
shorter 6 hours etoposide treatment is sufficient to increase 
Figure 6: Irreparable DSBs induced by a 16 hour etoposide treatment lead to an increased interaction of MTA3 
with HIC1 and favor its recruitment to the HIC1-response elements in the SIRT1 promoter. (A) Etoposide-induced non-
repairable DSBs lead to an increase of MTA3 interaction with HIC1. HEK293T cells were transfected with the indicated combination 
of empty FLAG, FLAG-HIC1, and FLAG-MTA3 expression vectors. 32 hours after transfection cells were incubated for 16 hours with 
20 μM etoposide (+) or with DMSO (–) as control. After lysis in IPH buffer, cell extracts were co-immunoprecipitated with anti-MTA3 
antibodies. The immunoprecipitates as well as 1% of the whole cell extracts were analyzed by SDS/PAGE and transferred to membranes. 
Relevant pieces of the membranes were cut and analyzed by Western blot with anti-FLAG antibodies to detect MTA3 and HIC1. ΔH2AX 
and actin levels were used as controls for DSB induction and equal loading, respectively. (B) Etoposide-induced irreparable DSB lead 
to an increase of MTA3 recruitment on the HiRE in the SIRT1 promoter. Chromatin was prepared from BJ-hTERT fibroblasts mock-
treated with DMSO or treated with 80 uM etoposide for 16 hours to induce irreparable DSB and ChIP experiments were performed with 
antibodies against MTA3 or rabbit IgG. The bound material was eluted and analysed by quantitative PCR using primers flanking the HIC1-
responsive elements (HiRE) in the SIRT1 promoter [6], as previously described [46]. GAPDH was used as a nonbinding control. Values 
that are statistically significantly different are indicated by bars and asterisks as follows: *P < 0.05. NS corresponds to values that are not 
statistically significantly different.
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HIC1 recruitment to the SIRT1 promoter (Figure 7) and to 
induce a P53-dependent apoptotic response while limiting 
the induction of indirect HIC1 target genes.
 Identification of new potential target genes 
regulated by HIC1 SUMOylation
Given our findings of the important role played by 
HIC1 SUMOylation in the transcriptional response to 
irreparable DSBs, we chose to employ a gene expression 
profiling approach to identify candidate genes for HIC1-
mediated transcriptional repression after the induction 
of DNA damage. BJ-hTERT cells transfected with either 
siHIC1 (HIC1-) or sicontrol (HIC1+) oligomers were 
subjected to etoposide induced DNA damage. Western blot 
analyses confirmed the efficient inactivation of HIC1 by 
the siRNA as well as the induction of P53 and p21 after 
etoposide treatment (Supplementary Figure S5B). Total 
RNA was isolated from treated and untreated cells in 
triplicate and subjected to gene expression profiling using 
the ILLUMINA HumanHT-12 v4 Expression BeadChip 
kit. To identify potential target genes, two normalization 
strategies were employed. In the first, HIC1+ and HIC1- 
etoposide treated cells (conditions II and IV) were first 
normalized to their untreated counterparts (conditions I and 
III) to identify genes that became repressed as a result of 
Figure 7: HIC1 and MTA1 recruitment to the HIC1-response elements in the SIRT1 promoter is increased upon 
induction of non-repairable DSBs. (A) HIC1 recruitment to the HiRE in the SIRT1 promoter in various conditions. Chromatin was 
prepared from BJ-hTERT fibroblasts not-treated, mock-treated with DMSO or treated with 80 μM etoposide for various times and ChIP 
experiments were performed with antibodies against HIC1 or rabbit IgG. The bound material was eluted and analysed by quantitative PCR 
using primers flanking the HIC1-responsive elements (HiRE) in the SIRT1 promoter [6], as previously described [46]. GAPDH was used as 
a nonbinding control. (B) Etoposide-induced irreparable DSBs lead to an increase of HIC1 and MTA1 recruitment to the HiRE in the SIRT1 
promoter. Chromatin was prepared from BJ-TERT fibroblasts mock-treated with DMSO or treated with 20 mM etoposide for 16 hours to 
induce irreparable DSBs and ChIP experiments were performed with antibodies against HIC1, MTA1 or rabbit IgG as described in panel 
A). Values that are statistically significantly different are indicated by bars and asterisks as follows: *P < 0.05, **P < 0.01. NS corresponds 
to values that are not statistically significantly different.
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DNA damage. In order to determine which of those genes 
were candidates for SUMO-HIC1 mediated repression, the 
list of repressed genes in HIC1- cells was subtracted from 
those repressed in HIC1+ cells yielding 629 genes repressed 
in a HIC1 replete context and not in the absence of HIC1 
(Figure 8A, solid lines; Supplementary  Table S1). In the 
second normalization strategy, mRNA expression from 
both the HIC1+ and HIC1- BJ-hTERT cells that were treated 
with etoposide (conditions II and IV) were compared 
back to the HIC1 sufficient untreated cells (condition I). 
The transcripts that were significantly repressed in the 
HIC1- context were subtracted from those repressed 
in the HIC1+ cells leaving 475 genes whose repression 
was potentially mediated by HIC1 (Figure 8A, dashed 
lines; Supplementary Table S2). The agreement between 
the resulting gene lists was substantial with 319 genes 
representing the intersection of these gene sets (Figure 8B, 
Supplementary Table S3). It is important to note that these 
genes likely represent both direct and indirect HIC1-
mediated transcriptional repression. The union of these 
lists (785 genes) was used to identify interaction maps 
using Ingenuity Pathway Analysis software. The top 
canonical pathway mapped by the repressed gene set was 
“Role of BRCA1 in DNA Damage Response”. Measured 
by the number of molecules represented, “Cell Death” 
and “Cell Cycle” were the top cellular functions identified 
Figure 8: Identification of the genes regulated in BJ-hTERT human fibroblasts by HIC1 in the presence and absence 
of etoposide to induce irreparable DSB. (A) Schematic drawing of the experimental design of the study and of the 2 normalization 
strategies used to identify the genes regulated by HIC1 in the presence and absence of a 6 hours etoposide treatment to induce irreparable 
DSBs. Four experimental conditions were used and compared using two different comparison strategies. In the first comparison strategy 
(Strategy #1 : normalization of IV to III, shown as black lines), BJ-hTERT siCtrl cells treated with etoposide were compared to control 
cells (siCtrl, no etoposide) to define genes repressed by etoposide and thus containing a subset of genes repressed by SUMOylated HIC1. 
Then, BJ-hTERT siHIC1 cells treated or not with etoposide were compared to define genes still repressed by etoposide in a HIC1-deficient 
context. Subtracting [IV] from [II] yields 629 target genes repressed in response to DSBs and dependent upon HIC1 SUMOylation. In the 
second strategy (Strategy #2: normalization of IV to I, shown as dotted lines), BJ-hTERT  siCtrl and BJ-hTERT siHIC1 cells, both treated 
with etoposide, were each compared to control cells (siCtrl, no etoposide). In that case, subtracting [IV] from [II] yields 475 target genes. 
(B) Venn diagrams showing the overlap of the 629 and 475 target genes from the 2 normalization strategies used yields a strong overlap of 
319 genes (see text for detail).
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with 80 and 58 genes represented respectively (data not 
shown). Since HIC1 SUMOylation increases its interaction 
with MTA1, we next compared these HIC1 target genes 
with MTA1 target genes obtained through gene profiling 
experiments of wt and Mta1–/– murine embryos fibroblasts 
(MEFs) [26]. This comparison highlighted 17 genes 
(Figure 9A). Among them, CXCl12, EPHA4, LPHN2, 
TGFβR3 and TRIB2 were validated by qRT-PCR as 
potential target genes regulated by HIC1 SUMOylation. 
Indeed, they are activated in siHIC1 BJ-hTERT fibroblasts 
as compared to siCtrl cells in control conditions (DMSO) 
and further repressed in siCtrl cells treated with etoposide 
(Figure 9B). Thus, we were able to place HIC1 and its 
interaction with NuRD complexes through its increased 
SUMOylation among the canonical pathways responsible 
for the transcriptional response to irreparable DSBs 
while yielding further potential targets of HIC1 for future 
validation.
DISCUSSION
The cellular response to different types of DNA 
damages involves a complex interplay of various post-
translational modifications including phosphorylation 
by PIKK kinases, Ubiquitinylation, PARylation and 
SUMOylation among many others [27–29]. SUMOylation 
is a very dynamic post-translational modification, involved 
essentially in regulation of protein-protein interaction and 
organization of macromolecular complexes through SIMs 
(SUMO-interacting motifs) that allow effector proteins to 
engage SUMO-modified substrates [12, 30]. Numerous 
proteins modified by SUMOylation have been identified 
and many of them are associated with transcriptional 
repression [30, 31]. SUMOylation is also a very labile 
PTM affecting only a small percentage of target proteins, 
the so-called “SUMO paradox” [12] and is thus difficult 
to detect. It is also becoming increasingly clear that 
SUMOylation plays a key role in the regulation of DNA 
damage repair and responses with, for example, an 
increased presence of SUMO at sites of DNA damage [27] 
and an orchestrated SUMOylation of subsets of chromatin 
remodelers to decrease global transcription upon DNA 
damage [32, 33]. SUMOylation is also implicated 
in another important aspect of the repair process, 
determining the kinetics and mechanisms for the repair 
of DSBs occurring either in open and transcriptionally 
active euchromatin or in highly compacted and 
transcriptionally inactive heterochromatin [34, 35]. The 
chromatin compaction found in heterochromatin on one 
hand protects it from DNA damages but on the other 
hand impairs the repair process once the damage occurs. 
Therefore, the majority of DSBs in heterochromatin are 
repaired with slow kinetics through ATM-dependent 
mechanisms of chromatin “relaxation”, as exemplified 
by the ATM-mediated phosphorylation of KAP1. KAP1, 
the obligate co-repressor for KRAB zinc fingers, the 
largest family of zinc-finger transcription factors, can 
undergo SUMOylation. KAP1 SUMOylation mediates 
its interaction with NuRD complexes owing to a SIM 
motif found in the C-terminal part of the ATP-dependent 
chromatin remodeling subunit CHD3 [36]. Upon DSB 
induction, phosphorylation of KAP1 Ser804 produces 
a SIM-like domain which interferes with the KAP1-
SUMO/SIM-CHD3 interaction thereby causing dispersal 
of CHD3/NuRD from the DSBs and chromatin relaxation 
allowing repair to occur [37, 38].
In this manuscript, we have studied in-depth the 
SUMOylation of the transcriptional repressor HIC1 
in various aspects of the DDR to DSBs. Indeed, HIC1 
was originally characterized as a tumor suppressor gene 
encoding a transcriptional repressor facilitating the P53 
dependent apoptotic response [4, 6, 5]. But HIC1 is also 
involved in the repair of DSBs since BJ-hTERT fibroblasts 
treated for 1 hour with etoposide and siRNAs targeting 
HIC1 repairs DSBs less efficiently than cells treated with 
control siRNAs [8]. Therefore, the current study nicely ties 
together HIC1 and the two major areas of SUMOylation 
research, the role of SUMOylation in transcriptional 
repression and its role in the DNA damage response 
[30, 33]. In that setting, we previously demonstrated 
an ATM-dependent increase in HIC1 SUMOylation 
favoring the interaction with MTA1, a core component 
of NuRD chromatin remodeling complexes in response 
to irreparable DSBs induced by a 16 hour etoposide 
treatment [8, 11]. On the contrary, HIC1 SUMOylation 
remains globally at basal levels when cells are exposed to 
etoposide for 1 hour to induce repairable damage, even in 
presence of the ATM inhibitor Ku-56933 (Figure 1). To 
date the only functions ascribed to HIC1 SUMOylation 
are to increase the transcriptional repression potential of a 
HIC1-Gal4 chimera in transient luciferase assays [10] and 
to enhance the interaction of HIC1 with the corepressor 
MTA1 [8, 11]. Even though its SUMOylation levels did 
not increase, HIC1 can still be SUMOylated when cells 
are exposed to etoposide for 1 hour and SUMOylation 
is one of the major post-transcriptional modifications 
involved in the DNA damage response [27]. However, 
results of the Comet assays performed with the non-
SUMOylatable HIC1 E316A strongly argue against a 
positive role of HIC1 SUMOylation and hence of HIC1-
NuRD interactions in the well documented functions 
for SUMOylation in DSBs repair: inhibition of local 
transcription at DSBs, repression of target genes during the 
repair process or heterochromatin relaxation (Figure 10).  
In contrast to the obvious lack of necessity for the 
cellular response to repairable DSBs demonstrated in this 
study, the increase of HIC1 SUMOylation, important for 
the response to irreparable damage, has previously been 
shown to be dependent on ATM (Figure 3) [8]. We have 
further refined this finding by showing that this HIC1 
SUMOylation increase is independent of the effector 
nucleoplasmic kinase, Chk2 (Figure 4). Since ATM is 
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stabilized and activated at chromatin, these results are in 
strong agreement with the “on-site modification” model 
for SUMOylation [39]. Furthermore, we have shown that 
the functionally distinct MTA3 corepressor also interacts 
with HIC1 in a SUMOylation-dependant manner. In ChIP 
experiments, we also observed an increased binding of 
HIC1 to the SIRT1 promoter. This could be explained at 
least in part by the increased SUMOylation of HIC1 since 
SUMOylation increased the DNA-binding properties of 
the BTB/POZ transcriptional repressor PLZF [23, 24] and 
the POU transcription factor Oct4 [40]. As a whole, these 
results firmly link the increase of HIC1 SUMOylation to 
a role in the transcriptional repression of target genes by 
NuRD repressive complexes to orchestrate the apoptotic 
Figure 9: Identification of target genes potentially regulated in BJ-hTERT human fibroblasts by HIC1 SUMOylation 
and MTA1. (A) Venn diagrams showing the overlap of the 475 target genes from the normalization strategy #2 and the 1024 genes 
affected by MTA1 knock out in murine embryonic fibroblasts (MEFs) [26]. (B) Validation by qRT-PCR of the microarray data showing 
differential regulation of some selected genes in BJ-hTERT cells. RNAs were extracted from BJ-hTERT using the same four experimental 
conditions as in the microarrays analyses. Selected genes (CXCl12, EPHA4, LPHN2, TGFβR3 and TRIB2) were analysed by qRT-PCR 
analyses and showed the expected differential regulation (see text for detail).The expression of HIC1 and of its direct target genes SIRT1 
and P21 were also tested as positive controls.
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DNA damage response (Figure 10). Two key genes in 
this process are SIRT1 [6] and p21 [25]. To have a more 
global vision of the HIC1 target genes involved in the 
transcriptional DNA damage response to non-repairable 
DSBs, we have conducted gene profiling analyses of BJ-
hTERT fibroblasts with or without HIC1 inactivation by 
RNA interference and treated or not with etoposide for 
6 hours. Through two thorough normalization strategies 
we were able to identify 475 genes regulated by HIC1 
in an etoposide-dependent manner (Figure 9). In good 
agreement with the longstanding role of HIC1 in the 
P53-dependent apoptotic response [6] and the importance 
of HIC1 SUMOylation in this process as shown by our 
previous work [8, 10, 11] and extended in this study, 
many of these genes are implicated in cell death and 
cell cycle control. Further crossing these 475 genes with 
known MTA1 target genes highlighted 17 common genes, 
which could be HIC1 direct or indirect target genes. 
Among them, we validated by qRT-PCR analyses three 
receptors, the Ephrin A4 tyrosine kinase receptor, the 
GPCR receptor Latrophilin2 (LPHN2) and the TGF-beta 
type III receptor, a membrane proteoglycan that often 
functions as a co-receptor with other TGF-beta receptor 
superfamily members. Interestingly, we also defined as 
potential new HIC1 target genes TRIB2, a pro-apototic-
molecule belonging to the atypical protein kinase family 
Tribbles [41] and SDF-1/CXCL12, a chemokine which is 
the ligand for the G-protein coupled chemokine (C-X-C 
motif) receptors, CXCR4 and CXCR7, the latter being a 
direct HIC1 target gene [42, 43].
In conclusion, our work demonstrates that HIC1 
SUMOylation is dispensable for DNA DSB repair but 
essential as a transcriptional repressor for the apoptotic 
response in the case of irreparable DSBs. Further studies 
are currently in progress to decipher the functional role of 
HIC1 in DNA repair. In particular, we are trying to identify 
potential HIC1 PTMs specifically induced when cells are 
exposed to repairable DSBs. These analyses would help to 
better decipher and understand the contribution of HIC1 to 
the repair process. 
MATERIALS AND METHODS
Cell lines and transfection
Cos-7, HEK293T and BJ-hTERT cells were 
maintained in Dulbecco modified Eagle medium 
(Invitrogen) supplemented with 10% fetal calf serum, non-
essential amino acids and gentamycin. Cells were cultured 
at 37°C in humidified 5% CO2 atmosphere.
Figure 10: HIC1 SUMOylation is dispensable for DNA repair but essential for the transcriptional response to non-
repairable DSBs. (A) Upon induction of repairable DSBS, HIC1 participates in the early steps of the repair process [8] by a mechanism 
that still remains to be deciphered. However, this is independent of HIC1 SUMOylation but could be due to other post-translational 
modifications. (B) Upon induction of non-repairable DSBs, the activated ATM kinase increases HIC1 SUMOylation which in turn enhances 
the binding of HIC1 to its responsive elements (HiRE) in the promoters of target genes (e.g. SIRT1) as well as the interaction of HIC1 with 
the MTA1 or MTA3 co-repressors to increase the transcriptional repression of direct target genes.
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Plasmids and chemicals
The expression vectors for full-length FLAG-HIC1, 
the non-SUMOylatable FLAG-HIC1 E316A, for His-
SUMO2, Myc-MTA1, the non SUMOylatable Myc-MTA1 
K509R and SIM-deficient Myc-MTA1 AAA mutants have 
been described previously [8, 10, 19]. The ΔMKHEP 
deletion mutant was generated by the two-round PCR 
mutagenesis strategy.
Etoposide and the Chk2 inhibitor C3742 (Chk2 
inhibitor II hydrate) were purchased from Sigma-Aldrich. 
Wortmannin (Calbiochem), a PI3K inhibitor which 
also inhibits PIKKs and ATM (KU-55933; Santa Cruz 
Biotechnology) and DNA-PKcs (NU-7441, Selleckchem) 
inhibitors were dissolved in DMSO and used at a final 
concentration of 10 µM. Inhibitors were added to culture 
medium 1 hour before subsequent treatments. 
Transfection and co-immunoprecipitation
Cells were transfected in Opti-MEM (Invitrogen) 
by the PEI method using ExGen 500 (Euromedex) as 
previously described with 2.5 µg of DNA corresponding to 
the relevant expression vectors or the empty vector used as 
control. Cells were transfected for 6 h and then incubated 
in fresh complete medium. 
For co-immunoprecipitation analyses (Co-IPs), 
48 h after transfection, cells were rinsed with cold PBS 
and lysed in cold IPH buffer (50 mM Tris, 150 mM 
NaCl, 5 mM EDTA, 0.5% NP40, protease inhibitor 
cocktail [Roche]). Cell lysates were sonicated briefly and 
cleared by centrifugation (14,000 rpm, 4°C, 15 min). The 
supernatants were pre-cleared with 15 µl of protein A/G 
sepharose beads (Amersham Bioscience) incubating during 
1 hour on a rotator at 4°C. Then, lysates were incubated 
with 2 µg of antibody on a rotator at 4°C overnight. Later, 
20 µl of protein A/G beads were added and incubated 
30 min at 4°C. Finally, the beads were washed three times 
with IPH buffer. Bound proteins were eluted by boiling in 
Laemmli buffer before analyses by SDS/PAGE followed 
by immunoblotting.
Small interfering RNA
HEK293T cells were reverse-transfected with 
Lipofectamine RNAiMax (Invitrogen) according to 
manufacturer’s instructions using 10 nM small interfering 
RNA targeting Chk2 (Human CHEK2 siGENOME- 
SMARTpool M-003256-06-0005, Dharmacon), ATM 
(Human ATM siGENOME siRNA-SMARTpool 
M-003201-04-0005, Dharmacon) or a scrambled control 
sequence (si Ctrl; siGENOME RISC free control siRNA, 
Dharmacon). For DNA-PKcs (referenced as PRKDC), we 
prepared a pool with four individual ON-TARGET plus 
PRKDC siRNAs (LQ-005030-00-0005, Dharmacon) or 
tested these four siRNAs individually [44]. 24 hours after 
siRNA transfection, cells were transfected with FLAG or 
FLAG-HIC1 vectors and treated with etoposide 24 hours 
later as previously described [8].
Comet assays
Cos7 cells were transfected for 48 h with expression 
vectors either for wt FLAG-HIC1 and the empty FLAG 
expression vector or for the non-SUMOylatable point 
mutant FLAG-HIC1 E316A and analyzed by neutral 
Comet assays, as previously described [8, 44]. For each 
condition, 2,000 cells were suspended in 80µl of 0.5% 
low melting point agarose at 42°C. The suspension was 
immediately laid onto a comet slide (TREVIGEN Inc.). 
Agarose was allowed to solidify at 4°C for 20 min. The 
comet slides were then immersed in prechilled lysis 
solution (1.2 M NaCl, 100 mM EDTA, 10 mM Tris, 1% 
Triton, pH = 10) at 4°C, for 90 min in the dark. Comet 
slides were next placed in a horizontal electrophoresis 
unit, and let to equilibrate in electrophoresis buffer (Tris 
89 mM, Boric acid 89 mM, EDTA 2 mM, pH8 to detect 
double strand breaks) for 10 min at 4°C, in the dark. After 
migration (40 V for 25 minutes), the slides were stained 
with SYBR green (Molecular Probes-1000X) according to 
manufacturer’s recommendations. 
Quantitative RT-PCR
Total RNA was reverse transcribed using random 
primers and MultiScribeTM reverse transcriptase (Applied 
Biosystems). Real-time PCR analysis was performed by 
Power SYBR Green (Applied Biosystems) in a MX3005P 
fluorescence temperature cycler (Stratagene) according to 
the manufacturer’s instructions. Results were normalized 
with respect to 18S RNA used as an internal control 
[45]. The primers used for the qRT-PCR analyses are 
summarized in Supplementary Table S4.
Western blotting and antibodies
Proteins were separated by SDS-PAGE and 
transferred onto nitrocellulose membranes (GE 
healthcare). Western blot analyses were performed as 
previously described [8]. 
Commercial antibodies of the following specificities 
were used: FLAG M2 from Sigma; Anti MTA1 (sc-9445 
for WB and sc-10813 for IP) from Santa Cruz and Anti 
MTA3 (ab87275) from Abcam; γH2AX, H2AX (total), 
pS1681ATM, ATM total, DNA-PKcs total, DNA-PKcs 
(pS2056) from Abcam, Chk2, pS516Chk2, pT68Chk2 
pS20P53 and anti-actin antibodies (sc-1616-R) from 
Santa Cruz Biotechnology. The secondary antibodies were 
horseradish peroxidase-linked antibodies against rabbit, 
rat and mouse immunoglobulins (Amersham Biosciences); 
goat immunoglobulins (Southern Biotech). 
To analyze the SUMOylation of HIC1 proteins by 
Western blotting analyses, transfected HEK293T cells 
pelleted by centrifugation were directly lysed in Laemmli 
Oncotarget2933www.impactjournals.com/oncotarget
loading buffer, boiled for 10 minutes and processed for 
Western blotting as described above. 
Chromatin immunoprecipitation 
Human BJ-hTERT fibroblasts were treated with 
DMSO or Etoposide for 16 hours, washed with PBS 
and resuspended in 0.5 ml PBS for 5 × 106 cells. Then, 
cells were fixed by adding formaldehyde to a final 
concentration of 1% for 8 min at room temperature. To 
stop fixation, glycine was added to a final concentration 
of 0.125 M. After 5 min at room temperature, cells were 
collected by centrifugation (1500 rpm, at 4°C, 5 min). 
The supernatants were removed and we lysed cells 
by resuspension in chilled cell lysis buffer for 10 min 
on a rotator at 4°C. Then, the samples were pelleted, 
resuspended in 200 µl nuclei lysis buffer and sonicated to 
chromatin with an average size of 250 bp using a cooling 
BioRuptor (Diagenode, Belgium). 20 µg of chromatin was 
immunoprecipitated with indicated antibodies and real-
time PCR analyses were performed as described [22]. The 
primers used for GAPDH, SIRT1 and ATOH1 have been 
previously described [46].
Microarrays analyses
Total RNA was prepared from BJ-hTERT human 
fibroblasts transfected with siCtrl or siHIC1 and mock-
treated (DMSO) or treated with etoposide for 6 hours. 
Samples were prepared for gene expression microarrays 
using the Illumina® TotalPrep™-96 RNA Amplification 
Kit (Ambion, Austin, TX). In brief, 200 ng of total RNA 
for each sample underwent 1st and 2nd strand cDNA 
synthesis followed by an in vitro transcription (IVT) 
amplification that generates biotinylated, antisense RNA 
copies of each mRNA, referred to as cRNA. For each 
sample, 750 ng of cRNA was hybridized to a HumanHT-
12v4 BeadChip array (Illumina, Inc., San Diego, CA) for 
16 hours, followed by washing, blocking, and streptavidin-
Cy3 staining according to the Whole-Genome Gene 
Expression Direct Hybridization protocol (Illumina, 
Inc., San Diego, CA). The arrays were scanned using an 
Illumina HiScanSQ System and the resultant image files 
were analyzed by GenomeStudio™ Gene Expression 
Module (Illumina, Inc., San Diego, CA). Significance 
of repression was determined in a comparison context 
between etoposide treated and null in the HIC1 replete 
context using an FDR corrected p-value of 0.05 regardless 
of magnitude.
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